Growth potential Target the Pivot insulin delivery platform market expansion, leveraging Modular Medical’s recent FDA submissions, payor reception studies, and planned U.S. rollout to identify opportunities with medical device distributors, health systems, and specialty pharmacies.

Strategic partnerships Leverage collaborations with IMO Health and Inizio to position Modular Medical as a data-driven, clinically guided insulin delivery solution, opening conversations with hospital networks, ACOs, and payer partners seeking integrated EHR workflows and real-time patient identification.

Clinical leadership Engage clinical influencers and the Pivot Innovation Council to co-create pilot programs and real-world evidence, accelerating market adoption by highlighting improved outcomes, streamlined workflows, and reimbursement pathways.

Payor advocacy Capitalize on positive payor reception data for Pivot by aligning with payer-specific value dossiers, pharmacy-channel reimbursement strategies, and cost-of-care analyses to shorten time-to-market in target regions.

Digital enablement Promote the AI-enabled clinical workflow integrations and software enhancements as features that reduce training time and support patient identification, making the Pivot system attractive to health systems prioritizing ease of adoption and interoperability.